ArticleOncology letters2020

KD025, an anti-adipocyte differentiation drug, enhances the efficacy of conventional chemotherapeutic drugs in ABCG2-overexpressing leukemia cells.

Wen Jing et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.